Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.

ABSTRACT:

SUBMITTER: Ludwig H 

PROVIDER: S-EPMC5383929 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature